Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: A population-based experience

Thrombosis Research

Volumn 130, Issue 1, 2012, Pages 27-31

  Onitilo, Adedayo A ^a,b   Doi, Suhail A R ^b   Engel, Jessica M ^a   Glurich, Ingrid ^a   Johnson, John ^a   Berg, Richard ^a  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast cancer; DVT; Tamoxifen; VTE

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TAMOXIFEN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER STAGING; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DRUG EXPOSURE; DRUG UTILIZATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CLUSTER ANALYSIS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAMOXIFEN; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84861794862     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.11.025     Document Type: Article

References (25)

1. J. Cuzick, J.F. Forbes, I. Sestak, S. Cawthorn, H. Hamed, and K. Holli International Breast Cancer Intervention Study Investigators. Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial J Natl Cancer Inst 99 2007 272 282
2. A. Decensi, P. Maisonneuve, N. Rotmensz, D. Bettega, A. Cost, and V. Sacchini ffect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial Circulation 111 2005 650 656
3. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 2005 1687 1717
4. S. Noble, and J. Pasi Epidemiology and pathophysiology of cancer-associated thrombosis Br J Cancer 102 Suppl. 1 2010 S2 S9
5. J. Ragaz, and A. Coldman Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes J Clin Oncol 16 1998 2018 2024
6. J. Cuzick, T. Powles, U. Veronesi, J. Forbes, R. Edwards, and S. Ashley Overview of the main outcomes in breast-cancer prevention trials Lancet 361 2003 296 300
7. C. Duggan, K. Marriott, R. Edwards, and J. Cuzick Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer J Clin Oncol 21 2003 3588 3593
8. S.Z. Goldhaber Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective Circulation 111 2005 539 541
9. R.K. Hernandez, H.T. Sorensen, L. Pedersen, J. Jacobsen, and T.L. Lash Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study Cancer 115 2009 4442 4449
10. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 2003 I17 I21
11. R.R. Love, D.A. Wiebe, J.M. Feyzi, P.A. Newcomb, and R.J. Chappell Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment J Natl Cancer Inst 86 1994 1534 1539
12. P. Prandoni, A. Falanga, and A. Piccioli Cancer and venous thromboembolism Lancet Oncol 6 2005 401 410
13. American Cancer Society Breast Cancer Facts & Figures 2009-2010 Available at: http://www.cancer.org/research/cancerfactsfigures/ breastcancerfactsfigures/breast-cancer-facts - figures-2009-2010 May 7, 2011 Accessed
14. [No authors listed.] Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group Lancet 351 1998 1451 1467
15. R.S. Braithwaite, R.T. Chlebowski, J. Lau, S. George, R. Hess, and N.F. Col Meta-analysis of vascular and neoplastic events associated with tamoxifen J Gen Intern Med 18 2003 937 947
16. E. Sirohi, and P. Peissig Study of effect of drug lexicons on medication extraction from electronic medical records Pac Symp Biocomput 2005 308 318
17. H.A. Guess Exposure-time-varying hazard function ratios in case-control studies of drug effects Pharmacoepidemiol Drug Saf 15 2006 81 92
18. S. Durrleman, and R. Simon Flexible regression models with cubic splines Stat Med 8 1989 551 561
19. B. Fisher, J.P. Costantino, D.L. Wickerham, R.S. Cecchini, W.M. Cronin, and A. Robidoux Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study J Natl Cancer Inst 97 2005 1652 1662
20. H.A. Guess Behavior of the exposure odds ratio in a case-control study when the hazard function is not constant over time J Clin Epidemiol 42 1989 1179 1184
21. D. Grady, and V.L. Ernster Endometrial Cancer D. Schottenfeld, J.F. Fraumeni Jr. Cancer Epidemiology and Prevention 2nd ed. 1996 Oxford University Press New York, NY 1058 1089
22. J. Miller, B.K. Chan, and H.D. Nelson Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force Ann Intern Med 136 2002 680 690
23. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, and B. Riggs Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
24. A. Falanga, and L. Zacharski Deep vein thrombosis in cancer: the scale of the problem and approaches to management Ann Oncol 16 2005 696 701
25. T. Saphner, D.C. Tormey, and R. Gray Venous and arterial thrombosis in patients who receive adjuvant therapy for breast cancer J Clin Oncol 9 1991 286 294